HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Bullish On Consumer Health’s Prospects Despite ‘Challenging’ 2018

Executive Summary

Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.

You may also be interested in...



Bayer R&D Center To Uncover Chinese Insights

A new dedicated R&D facility for Bayer Consumer Health in China will enable the firm to “quickly take the pulse of the market” and transform demand into innovative products.

Bayer's Consumer Health Struggles Continue In Q1, But The Firm Insists It's On The Right Track

Bayer Consumer Health's sales declined at a single-digit rate in the first quarter of 2019, as the business continued to battle challenges in Europe and the US. Undeterred by this slow start to the year, the German firm says Consumer Health's performance will begin to turnaround in the coming months. 

Manufacturing Moves: Bayer Upgrades Americas Production, GSK To Shutter Nigeria Plant

Bayer Consumer Health will supply 11 markets across the Americas after investing over $40m to upgrade its manufacturing site in Guatemala, while GSK has announced plans to shut its factory in Nigeria and rely on third-party providers.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS148581

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel